|
|
|
| Efficacy of Anticancer Regimen Combined with Gefitinib in the Treatment of Cancer-related Fatigue in Advanced Non-small Cell Lung Cancer Patient |
| HUAHG Feng-lin, LI Jian-zhe |
| Tianyang County Chinese Medicine Hospital 533600 |
|
|
|
|
Abstract 【Objective】To investigate the efficacy of anticancer regimen combined with gefitinib in the treatment of cancer-related fatigue and its impact on quality of life. 【Methods】A total of 123 patients with advanced non-small cell lung cancer (NSCLC) were divided into two groups according to the treatment methods. Patients in the control group(group B)received gefitinib, while patients in the observation group(group A) received gefitinib combined with anti-cancer treatment. The therapeutic effects, quality of life scores and the PFS score in the two groups before and after treatment were compared. 【Results】The PFS scores of the two groups were lower than those before treatment (P<0.05), and the decrease in group A was higher than that in group B (P<0.05). After treatment, the fatigue, rib pain, five upset fever and pulse weakness scores of the two groups were lower than before treatment (P<0.05).Those scores in group A were significantly lower than group B (P<0.05). The total remission rate of group A was 69.68%, which was significantly higher than group B (40.98%) (P<0.05). After treatment, the scores of physical function, role function and emotional function in the two groups were higher than those before treatment (P<0.05). The increase in the above scores in group A was higher than group B (P<0.05). Regression analysis showed that age and pathological grade were negatively correlated with quality of life in patients with advanced NSCLC. However, psychological intervention and treatment were positively correlated with quality of life in those patients. 【Conclusion】Anticancer combined with gefitinib is effective in treating cancer-related fatigue in patients with advanced NSCLC , and can significantly improve the quality of life of patients.
|
|
Received: 24 January 2019
|
|
|
|
|
|
[1] Jones J M, Olson K, Catton P, et al. Cancer-related fatigue and associated disability in post-treatment cancer survivors[J]. J Cancer Surviv, 2016, 10(1):51-61.
[2] Herrera C, Casellas F, Robles V, et al. Iron deficiency in the absence of anemia impairs the perception of health-related quality of life of patients with inflammatory bowel disease[J]. Inflamm Bowel Dis, 2016, 22(6):1450-1455.
[3] Rakhae A, Badve S, Eusebi V, et al. Breast lesions of uncertain malignant nature and limited metastatic potential: proposals to improve their recognition and clinical management[J]. Histopathology, 2016, 68(1):45-56.
[4] 范肖冬. ICD-10精神与行为障碍分类[M]. 北京:人民卫生出版社, 1993:25.
[5] Piper B F, Dibble S L, Dodd M J, et al. The revised piper fatigue scale: psychometric evaluation in women with breast cancer[J]. Oncol Nurs Forum, 1998, 25(4):677-684.
[6] Chie WC,Yang CH, Hsu C, et al. Quality of life of lung cancer patients: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13.[J]. Psychooncology, 2003, 12(7):729-735.
[7] 杨学宁, 吴一龙. 实体瘤治疗疗效评价标准-RECIST[J]. 循证医学, 2004, 4(2):85-90.
[8] 国家中医药管理局. ZY/T001. 1 ~ 001. 9-94中医病证诊断疗效标准[M]. 南京:南京大学出版社, 1994:12.
[9] 徐咏梅, 程培育, 杨国旺,等. 肺癌患者癌因性疲乏特点及中医证候的临床观察[J]. 中华中医药杂志, 2017(10):4746-4749. |
| [1] |
. [J]. JOURNAL OF CLINICAL RESEARCH, 2019, 36(5): 1012-1014. |
|
|
|
|
2019, Vol. 36 
